• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Feb. 4

    MO SCI Acquires Assets of 3M’s Advanced Materials Business

    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets

    Aspivix's Carevix Cervical Stabilizer Gains FDA OK

    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Deducing the Dual Reality of Elizabeth Holmes

    The Return of the AdvaMed MedTech Conference…Live!

    Material Matters: New Materials Call for New Thinking

    5 Ways to Maintain a Talent-Centric Mindset, Even During Economic Uncertainty

    The Changing Face of UK Medical Device Regulations: Most Recent Update
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Paragon Medical

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Medbio LLC

    Fusion Biotec Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Paragon Medical

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Medbio LLC

    Fusion Biotec Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Evolution of Chemical Characterization for Medical Devices

    Evaluation of biological safety of devices is experiencing some of the most significant changes in history.

    Related Content
    • Providien
    • Zeus
    • Laboratory Testing Inc.
    • JK Medirise-Disposable Medical Device Company
    • WuXi AppTec Medical Device Testing
    Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Medical Device Testing04.01.21
    In recent years, medical device manufacturers have faced rapidly evolving expectations about conducting biocompatibility testing to support preclinical product safety testing. With the recent changes to ISO 10993, the evaluation of biological safety of devices is experiencing some of the most significant changes in history.

    Regulators quickly adopted the publication of ISO 10993-1:2018 (Part 1) because it requires manufacturers to develop biological test strategies based on their devices' potential risks. With this new guidance, physical and chemical information should be the starting point for identifying device-specific risks.

    Additionally, the number of devices that fall within reach of ISO 10993-1 and corresponding guidance documents has rapidly expanded. Teams still familiarizing themselves with these evaluation processes and regulatory expectations should take the time to understand the history of the methods at hand, the thought process that has advanced it, and how to apply this historical lens moving forward.

    The Debut of Chemical Characterization
    Manufacturers became accustomed to conducting a more standardized set of tests based on their device's contact type and duration before the revised ISO 10993-1 was released in 2018. Testing strategies specific to the device were not common, and oftentimes, the testing that could reveal unknown risks, such as the chemical characterization and risk assessment, was the final task left before product approval submission. This approach could, at times, leave manufacturers scrambling at the last moment to mitigate unanticipated risks.

    During this period of time, the shift to identifying potentially harmful compounds earlier in the process was gaining traction with regulatory bodies. With the pathway to submission leaving little room for error, this new mindset often left sponsors with concerns they may not have planned to address.

    The U.S. Food and Drug Administration (FDA) created a launchpad for revising the standard through its 2016 Draft Guidance on the Use of ISO 10993 Part 1. The guidance outlined the role of chemical characterization in the process and the importance of addressing it first. This FDA guidance played an instrumental role in revising ISO 10993-1, which formalized chemical characterization and the subsequent risk assessment as a fundamental requirement in assessing a device's safety.

    Chemical characterization can take many forms, from a paper-based review of all materials to a targeted study focusing on one compound of concern. Most frequently, it requires an extractables study consisting of exaggerated extraction of the device, followed by an analysis of the chemical constituents using a range of analytical methods.

    In the early days, high-risk devices were typically the products that required chemical characterization. Slowly, chemistry became a requirement for other devices, including permanent implants, prolonged contacting devices, and devices in contact with circulating blood.

    The revised version of ISO 10993-1 was released in 2018 and created a new standard that prioritized chemical characterization in evaluating a medical device's biological safety. This standard continued to drive the shift in regulatory expectations and the changing approach to determining biocompatibility endpoints. As reviewers became savvier from a technical standpoint, they began to ask more questions and required manufacturers justify their scientific approach to chemical characterization.

    The Evolution of Testing Methods
    As testing evolved, regulators supported the refinement of acceptable testing plans to include chemical characterization. These analytically selective and sensitive methods began to prove their value as the industry shifted from a checklist approach to a more strategic method of biological safety testing. Over time, the requirements for conducting chemistry testing have improved and become more rigorous.

    One example of the evolving testing requirements is how the number of solvents applied by laboratories has increased in addition to the aggressiveness of the extractions themselves. The pendulum continued to swing, applying exhaustive extraction techniques to both prolonged and permanent devices. This change pushed a growing portion of the market to new lengths, which led to extended testing timelines and increasing costs.

    Identifying the compounds detected in chemical characterization studies was no longer nice-to-have information but mandatory for the risk assessment process. A more robust understanding of chemicals present allowed for improved risk assessments. Effectively interpreting this data often requires a collaborative team that is in tune with how each regulatory body interprets the guidance at the given moment.

    The publication of ISO 10993-18:2020 introduces the analytical evaluation threshold (AET), which is the conversion from a dose-based threshold used by toxicologists to a concentration-based threshold used by chemists. The AET requires a partnership between the chemist and the toxicologist who will perform the risk assessment. Together they use inputs including the frequency and duration of the medical device’s clinical use, the extraction information used in the laboratory, and the uncertainty of the analytical method(s) to determine a level for which compounds detected in the chemistry study need to be identified. Not only does it create a “common language” between two integral parts of the evaluation process, but it levels the playing field of what manufacturers should expect from their laboratory testing partners.

    Regulators are gradually implementing enhanced material identification expectations across the board and driving the importance of advanced chemical characterization. This is evident by the release of the FDA guidance, Use of International Standard ISO 10993-1, “Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process.” Manufacturers must be on their toes to keep up and consistently assess their compliance with the latest requirements.

    Continued Evolution, Continued Investments
    In a perpetual effort to better understand the chemical risks of devices entering the market, the industry continues to establish more consistent and thorough evaluation procedures that better recognize the risks associated with each device.

    The different chemical characterization methods are ever-evolving, and regulators expect more information from these studies, including a justification of the approach (i.e., choice of solvents, analytical method, and extraction conditions). To keep up with this process, manufacturers should maintain current records that include regulators' current expectations. Legacy products and those with testing procedures dated from even just a few years ago may have a lot of catching up to do.

    For many products, testing completed before the release of ISO 10993-18:2020 is likely obsolete with the current chemical characterization studies' expectations. Managing a range of products in this environment can be an arduous process during the transition, but the efforts will benefit patients in the long run.

    Looking Forward
    The medical device industry is always working toward ensuring patient safety remains the top priority, and the methods for supporting safety through testing will continue to evolve. Manufacturers should understand the latest requirements and be prepared to invest in a quality chemical characterization study to ensure a solid foundation for the rest of their program. In fact, in the next year or so, an updated ISO 10993-17 guidance document will provide manufacturers additional information on performing toxicological risk assessments of these chemical constituents.

    Medical device companies are responsible for evaluating their product’s safety before entering the market, but it is not a challenge they should face alone. Leaning on industry partners involved in the regulatory landscape can help companies stay relevant and competitive by maintaining the most up-to-date technical files. More information on regulatory expectations and some additional tips on preparing for regulatory requests and minimizing impact can be found at bit.ly/3qRiTFD. 


    Sandi Schaible is the senior director of analytical chemistry and regulatory toxicology at St. Paul, Minn.-based WuXi AppTec Medical Device Testing, which specializes in extractables and leachables studies. She is a U.S. delegate and international delegate for ISO 10993 part 18 in chemical characterization, and also a U.S. delegate for ISO 10993 part 13 and the particulates committee (TIR42).
    Related Searches
    • Testing
    Related Knowledge Center
    • Testing
    Suggested For You
    Providien Providien
    Zeus Zeus
    Laboratory Testing Inc. Laboratory Testing Inc.
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    WuXi AppTec Medical Device Testing WuXi AppTec Medical Device Testing
    DDL Inc. DDL Inc.
    sfm medical devices GmbH sfm medical devices GmbH
    Hangsterfer Hangsterfer's Laboratories
    Anjon Medical Technologies Anjon Medical Technologies
    IMA Automation North America IMA Automation North America
    Auriga Inc. Auriga Inc.
    WESTPAK Inc. WESTPAK Inc.
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    High Tech Turning Co. Inc. High Tech Turning Co. Inc.
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform

    Related Buyers Guide Companies

    • Providien

      Providien

      ...
      Bonalyn Boyd, Marketing Manager 11.30.22

    • Zeus

      Zeus

      ...
      Laura Bright, Ad Manager 11.18.22

    • Laboratory Testing Inc.

      ...
      Sharon Bentzley, Marketing Manager 11.17.22


    • JK Medirise-Disposable Medical Device Company

      ...
      Ketan Munjani, Marketing Manager 11.17.22

    • WuXi AppTec Medical Device Testing

      ...
      Tim Xi, Marketing Manager 11.11.22

    Loading, Please Wait..

    Trending
    • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
    • CGM Devices Could Become Main Glucose Monitoring Solution In U.S.
    • Environmental Sustainability Becoming Increasingly Important To Medtech Industry
    • The Future Of Biomedical Engineering Advancements
    • A New Approach To Post-Market Surveillance
    Breaking News
    • MPO's Most-Read Stories This Week—Feb. 4
    • MO SCI Acquires Assets of 3M’s Advanced Materials Business
    • Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
    • Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    • Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    View Breaking News >
    CURRENT ISSUE

    January/February 2023

    • Struggling Suppliers in Electronics Manufacturing Services (EMS)
    • Machining & Laser Processing Have Huge Parts to Play
    • Medtech R&D Teams Must Be Creative & Resilient to Survive
    • Medtronic Neuromodulation President, Nnamdi Njoku, Interview
    • 6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Coatings World

    Latest Breaking News From Coatings World

    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    10 Partners of the Automotive Industry Form JV, Cofinity-X
    BASF Recognized as Top Company for Supplier Diversity
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MO SCI Acquires Assets of 3M’s Advanced Materials Business
    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
    Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly 4Q Revenues Down 9% to $7.3B
    Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
    Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Pacifica Introduces Glow Baby Skincare Line
    Kohl’s Names Tom Kingsbury as Chief Executive Officer
    Mielle Unveils Haircare Bundles Inspired by Amazon Original Series Harlem
    Happi

    Latest Breaking News From Happi

    Grant Industries Names Mehran Ghadim Sales Manager, Canada
    Bio-Oil Celebrates Body Confidence Through Body Positivity Month Campaign
    Net Sales for Clorox Increase 1% for Q2 2023
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Pigments, Inkjet Ink Market Reports Top This Week’s Stories
    Roland DGA Announces Key Changes to Leadership Team
    Ball Reports 2022 Results
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    MM Packaging adds first Nilpeter press for Dublin site
    Polytag develops new UV tag reading technology
    Enterprise Print Group adds Screen Truepress Jet L350UV SAI E
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    What You’re Reading on Nonwovens-Industry.com
    Kimberly-Clark Supports Period Poverty Initiative in Australia
    Suominen Reports Q4, Full Year Results
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Toetal Solutions Secures $1.8 Million in New Financing
    Adrian Tyndall Joins Axogen's Board of Directors
    ADSM-Synchro Medical Acquired by Tyber Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: CES 2023, ams OSRAM and Celanese Top This Week’s Stories
    Zebra Provides East West Shrine Bowl with RFID Tracking Technology
    AAAS Elects Three ORNL Scientists as Fellows

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login